MLH1 and cancer: Thus, our vaccination approaches with shared peptides derived from coding regions may be also relevant in other MMRd contexts such as Mlh1 epigenetic silencing or Lynch Syndrome, a condition where the risk to develop cancer is increased by 80% (1).